Nancy J. Hutson is Director at BIOCRYST PHARMACEUTICALS INC (BCRX). They have made 28 open-market trades across 6 companies since 2007, most recently 2025-06-12.
CIK 0001379222
16 open-market purchases totalling $537K since 2007, against 12 sales. Across 12 scored buys the stock is up 15.7% at ninety days, and 9.9 points ahead of the S&P over the same stretch.
12 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 58% | 58% | 58% |
| Avg Move | +1.9% | +6.1% | +15.7% |
| Alpha | +2.6% | +4.8% | +9.9% |
| Scored | 12 | 12 | 12 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BCRX | SELL · 10b5-1 | 2024-12-13 | 2024-12-16 | $7.54 | $53K | +6.6% | +0.0% | +7.1% |
| BCRX | BUY | 2024-05-20 | 2024-05-22 | $6.38 | $32K | +1.0% | -3.7% | +17.2% |
| CLSD | BUY | 2023-10-03 | 2023-10-04 | $0.86 | $9K | +5.3% | +12.4% | +51.8% |
| BCRX | SELL | 2023-06-14 | 2023-06-15 | $8.04 | $207K | -10.8% | -10.1% | -14.0% |
| CLSD | BUY | 2022-11-17 | 2022-11-21 | $1.33 | $40K | +8.1% | -9.9% | +23.4% |
| BCRX | SELL | 2021-10-15 | 2021-10-19 | $15.40 | $1.6M | -0.3% | -21.5% | -2.7% |
| PHAS | BUY | 2021-08-18 | 2021-08-19 | $3.08 | $9K | +3.5% | -13.1% | -11.2% |
| CLSD | BUY | 2021-08-16 | 2021-08-17 | $5.68 | $17K | +34.6% | +21.5% | -9.7% |
| BCRX | SELL | 2021-06-10 | 2021-06-14 | $16.86 | $787K | +5.3% | -3.2% | -4.1% |
| CLSD | BUY | 2021-03-12 | 2021-03-15 | $3.11 | $16K | -22.8% | -16.6% | -5.6% |
| CLSD | BUY | 2020-05-20 | 2020-05-21 | $1.85 | $9K | +1.6% | +6.9% | -6.9% |
| BCRX | BUY | 2019-11-18 | 2019-11-18 | $1.45 | $15K | +60.1% | +77.5% | +64.3% |
| PHAS | BUY | 2018-12-17 | 2018-12-17 | $4.46 | $4K | -18.2% | +0.5% | +67.0% |
| ENDP | SELL | 2018-11-15 | 2018-11-16 | $12.83 | $128K | -3.6% | -25.1% | -16.6% |
| ENDP | SELL | 2017-03-09 | 2017-03-10 | $10.82 | $115K | -8.6% | +9.9% | +27.6% |
| ENDP | SELL | 2016-03-01 | 2016-03-03 | $42.19 | $288K | -24.7% | -34.3% | -61.6% |
| BCRX | BUY | 2015-02-20 | 2015-02-23 | $10.27 | $103K | -26.4% | -2.7% | -2.7% |
| CBST | SELL | 2014-08-18 | 2014-08-18 | $65.00 | $585K | N/A | N/A | N/A |
| ENDP | SELL | 2014-03-10 | 2014-03-11 | $72.12 | $361K | -11.9% | +0.1% | +0.1% |
| CBST | SELL | 2013-07-26 | 2013-07-29 | $53.87 | $269K | N/A | N/A | N/A |
| CBST | SELL | 2013-04-26 | 2013-04-26 | $46.23 | $231K | N/A | N/A | N/A |
| CBST | SELL | 2013-01-28 | 2013-01-30 | $43.27 | $216K | N/A | N/A | N/A |
| CBST | SELL | 2012-10-26 | 2012-10-30 | $43.52 | $218K | N/A | N/A | N/A |
| CBST | BUY | 2011-10-26 | 2011-10-28 | $38.66 | $58K | N/A | N/A | N/A |
| ENDP | BUY | 2010-12-07 | 2010-12-09 | $36.38 | $36K | -11.9% | +0.1% | +0.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.